Last edition
News about "Altor BioScience"
US FDA Approves First Treatment for BCG-Unresponsive Bladder Cancer
The US FDA has expanded approval of Anktiva, offering a new treatment option for certain patients with BCG-unresponsive bladder cancer.
Altor BioScience | 16/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members